OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
41 hedge funds and large institutions have $33.3M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.12M | |
| 2 | +$1.18M | |
| 3 | +$1.06M | |
| 4 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$477K |
| 5 |
D.E. Shaw & Co
New York
|
+$450K |
Top Sellers
| 1 | -$1.51M | |
| 2 | -$668K | |
| 3 | -$505K | |
| 4 |
DAM
DLD Asset Management
New York
|
-$265K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$265K |